Skip to main content
Premium Trial:

Request an Annual Quote

Linda Baddour, Gary Hendrickson

Waters announced today that has appointed Linda Baddour and Gary Hendrickson as directors of the firm.

Baddour has served as executive VP and CFO at PRA Health Sciences since 2007. Prior to PRA, she served as CFO at Pharmaceutical Product Development. Beforhand,  she also served as treasurer and chief accounting officer at the firm.

Prior to Waters, Hendrickson served as Chairman of  Valspar between 2012 and 2017, and CEO since 2011. Prior to CEO, Hendrickson acted as COO, president of several business units, and corporate VP and President of the firm's Asia Pacific branch.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.